Combination chemotherapy with cis-platinum and ifosfamide for hormone unresponsive prostate cancer

Japanese Journal of Urology

Volumn 89, Issue 7, 1998, Pages 657-664

  Maki, Yoshio ^a   Tsushima, Tomoyasu ^a   Nasu, Yasutomo ^a   Kumon, Hiromi ^a   Ohmori, Hiroyuki ^a   Tanahashi, Toyoko ^b   Nanba, Katsuichi ^b   Ohashi, Teruhisa ^c   Kondo, Katsuyoshi ^c   Saika, Takashi ^d   Asahi, Toshihiko ^d  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Okayama Citizens Hospital   (Japan)

^c Okayama Red Cross Hospital   (Japan)

^d Kagawa Prefectural Central Hospital   (Japan)

Author keywords

Chemotherapy; Hormone refractory; Prostate cancer

Indexed keywords

CHLORMADINONE ACETATE; CISPLATIN; DIETHYLSTILBESTROL PHOSPHATE; ESTRAMUSTINE PHOSPHATE; ETOPOSIDE; FLUTAMIDE; GONADORELIN DERIVATIVE; HORMONE; IFOSFAMIDE; PEPLEOMYCIN; VINCRISTINE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; HEMATURIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; MALE; NEPHROTOXICITY; PROSTATE CANCER; SEPTIC SHOCK; THROMBOCYTOPENIA;

EID: 7344236787     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.89.657     Document Type: Article

References (15)

1. Merrin, C.E. and Beckley, S. : Treatment of estrogen-resistant stage D carcinoma of the prostate with cisdiamminedichloroplatinum. Urology, 13, 267-272, 1979.
2. Loening, S.A., Beckley, S., Brady, M.F., Chu, T. M., DeKernion, J.B., Dhabuwala, C. Gaeta, J.F. Gibbons, R.P., McKiel, C.F., McLeod, D.G., Pontes, J.E. Prout, G.R., Scardino, P.T. Schlegel, J.U. Schmidt, J.D., Scott, W.W., Slack, N.H. Soloway, W.S. and Murphy. G.P. : Comparison of estramustine phosphate, methotrexate and cis-ptatinum in patient with advanced, hormone refractory prostate cancer. J. Urol., 129, 1001-1006, 1983.
3. Scott, W W., Gibbons, R.P., Johnson, D.E., Prout, G.R., Schmidt, J.D., Saroff, J. and Murphy, G.P. : The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate. J. Urol., 116, 211 -213, 1976.
4. Murphy, G.P., Priore, R.L. and Scardino, P.T. : Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. Urology, 32, 33-40, 1988.
5. DeWys, W.D., Begg, C.B., Brodovsky. H., Creech, R. and Khandekar, J. : A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer : Prognostic factors and response. Prostate, 4, 1-11, 1983.
6. Muss, H.B., Howard, V., Richards, F. II, White, D R., Jaclson, D.V., Cooper, M.R., Stuart, J.J., Resnick, M.I., Brodkin, R and Spurr, C.L. : Cyclohosphamide versus cyclophosphamide, methotrexate and 5-fluorouracil in advanced prostatic cancer : A randomized trial. Cancer, 47, 1949-1953, 1981.